NCT00114413View on ClinicalTrials.gov

Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in Adolescents

NACompletedINTERVENTIONAL
Enrollment

547

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Asthma
Interventions
DRUG

Inhaled corticosteroids

Used for both regular asthma control and as a rescue inhaler

PROCEDURE

eNO measurement

measured by Aerocrine® NIOX device

Trial Locations (12)

10032

Mount Sinai (DAIT-ICAC-01/02), New York

20010

Howard University, Washington D.C.

21205

Johns Hopkins University, Baltimore

27517

Rho Federal System Division, Inc- data coordinating center, Chapel Hill

44106

Rainbow Babies and Children's Hospital, Cleveland

53792

University of Wisconsin-an administrative site, Madison

60614

Children's Memorial Hospital, Chicago

63110

Washington University School of Medicine, St Louis

75235

University of Texas Southwestern (DAIT-ICAC-01/02), Dallas

80206

National Jewish Medical and Research Center (DAIT-ICAC-01/02), Denver

85724

University of Arizona (DAIT-ICAC-01/02), Tucson

02118

Boston University School of Medicine, Boston

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00114413 - Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in Adolescents | Biotech Hunter | Biotech Hunter